241 related articles for article (PubMed ID: 28286018)
1. Acyl glucuronide metabolites: Implications for drug safety assessment.
Van Vleet TR; Liu H; Lee A; Blomme EAG
Toxicol Lett; 2017 Apr; 272():1-7. PubMed ID: 28286018
[TBL] [Abstract][Full Text] [Related]
2. Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.
Darnell M; Breitholtz K; Isin EM; Jurva U; Weidolf L
Chem Res Toxicol; 2015 May; 28(5):886-96. PubMed ID: 25803559
[TBL] [Abstract][Full Text] [Related]
3. Acyl glucuronide reactivity in perspective: biological consequences.
Bailey MJ; Dickinson RG
Chem Biol Interact; 2003 May; 145(2):117-37. PubMed ID: 12686489
[TBL] [Abstract][Full Text] [Related]
4. A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides.
Zhong S; Jones R; Lu W; Schadt S; Ottaviani G
Drug Metab Dispos; 2015 Nov; 43(11):1711-7. PubMed ID: 26276581
[TBL] [Abstract][Full Text] [Related]
5. Acyl glucuronides: the good, the bad and the ugly.
Regan SL; Maggs JL; Hammond TG; Lambert C; Williams DP; Park BK
Biopharm Drug Dispos; 2010 Oct; 31(7):367-95. PubMed ID: 20830700
[TBL] [Abstract][Full Text] [Related]
6. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions.
Boelsterli UA
Curr Drug Metab; 2002 Aug; 3(4):439-50. PubMed ID: 12093359
[TBL] [Abstract][Full Text] [Related]
7. Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin.
Bolze S; Bromet N; Gay-Feutry C; Massiere F; Boulieu R; Hulot T
Drug Metab Dispos; 2002 Apr; 30(4):404-13. PubMed ID: 11901094
[TBL] [Abstract][Full Text] [Related]
8. Safety Assessment of Acyl Glucuronides-A Simplified Paradigm.
Smith DA; Hammond T; Baillie TA
Drug Metab Dispos; 2018 Jun; 46(6):908-912. PubMed ID: 29559442
[TBL] [Abstract][Full Text] [Related]
9. Hepatic disposition of electrophilic acyl glucuronide conjugates.
Sallustio BC; Sabordo L; Evans AM; Nation RL
Curr Drug Metab; 2000 Sep; 1(2):163-80. PubMed ID: 11465081
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Deprotonated Acyl-,
Niyonsaba E; Easton MW; Feng E; Yu Z; Zhang Z; Sheng H; Kong J; Easterling LF; Milton J; Chobanian HR; Deprez NR; Cancilla MT; Kilaz G; Kenttämaa HI
Anal Chem; 2019 Sep; 91(17):11388-11396. PubMed ID: 31381321
[TBL] [Abstract][Full Text] [Related]
11. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
[TBL] [Abstract][Full Text] [Related]
12. Acyl glucuronide drug metabolites: toxicological and analytical implications.
Shipkova M; Armstrong VW; Oellerich M; Wieland E
Ther Drug Monit; 2003 Feb; 25(1):1-16. PubMed ID: 12548138
[TBL] [Abstract][Full Text] [Related]
13. A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements.
Wang J; Davis M; Li F; Azam F; Scatina J; Talaat R
Chem Res Toxicol; 2004 Sep; 17(9):1206-16. PubMed ID: 15377154
[TBL] [Abstract][Full Text] [Related]
14. Acyl glucuronide reactivity in perspective.
Bradshaw PR; Athersuch TJ; Stachulski AV; Wilson ID
Drug Discov Today; 2020 Sep; 25(9):1639-1650. PubMed ID: 32681884
[TBL] [Abstract][Full Text] [Related]
15. Bioactivation of GPR40 Agonist MK-8666: Formation of Protein Adducts in Vitro from Reactive Acyl Glucuronide and Acyl CoA Thioester.
Shang J; Tschirret-Guth R; Cancilla M; Samuel K; Chen Q; Chobanian HR; Thomas A; Tong W; Josien H; Buevich AV; Mitra K
Chem Res Toxicol; 2020 Jan; 33(1):191-201. PubMed ID: 31566356
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
Gunduz M; Argikar UA; Cirello AL; Dumouchel JL
Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840
[TBL] [Abstract][Full Text] [Related]
17. New Perspectives on Drug-Induced Liver Injury Risk Assessment of Acyl Glucuronides.
Walles M; Brown AP; Zimmerlin A; End P
Chem Res Toxicol; 2020 Jul; 33(7):1551-1560. PubMed ID: 32525307
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of Carboxylic Acid-Containing Drugs: The Role of Acyl Migration and CoA Conjugation Investigated.
Lassila T; Hokkanen J; Aatsinki SM; Mattila S; Turpeinen M; Tolonen A
Chem Res Toxicol; 2015 Dec; 28(12):2292-303. PubMed ID: 26558897
[TBL] [Abstract][Full Text] [Related]
19. The generation, detection, and effects of reactive drug metabolites.
Stachulski AV; Baillie TA; Park BK; Obach RS; Dalvie DK; Williams DP; Srivastava A; Regan SL; Antoine DJ; Goldring CE; Chia AJ; Kitteringham NR; Randle LE; Callan H; Castrejon JL; Farrell J; Naisbitt DJ; Lennard MS
Med Res Rev; 2013 Sep; 33(5):985-1080. PubMed ID: 23090860
[TBL] [Abstract][Full Text] [Related]
20. Correlation between glucuronidation and covalent adducts formation with proteins of nonsteroidal anti-inflammatory drugs.
Shimada H; Kobayashi Y; Tanahashi S; Kawase A; Ogiso T; Iwaki M
Eur J Pharm Sci; 2018 Jan; 112():132-138. PubMed ID: 29174986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
